Clinical Trial Update: Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of nimotuzumab with radiotherapy for recurrent cervical squamous carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Lei Li | Conditions: Recurrent Cervical Carcinoma, Radiotherapy | Phase 2 | Status: UNKNOWN